RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Evaluating the clinical utility of the atopic dermatitis control tool
Measurement properties and agreement between patients' responses and clinicians' impressions of atopic dermatitis control
Simpson, EL., Eckert, L., Gadkari, A., Brown, TM., Lio, PA., Lockshin, B., Nelson, L., Fehnel, SE., Mahajan, P., Chao, JD., Nygardas, M., & Guillemin, I. (2024). Evaluating the clinical utility of the atopic dermatitis control tool: Measurement properties and agreement between patients' responses and clinicians' impressions of atopic dermatitis control. British Journal of Dermatology, 190(6), 917-919. https://doi.org/10.1093/bjd/ljae056
Previous analyses have demonstrated the validity and reliability of the Atopic Dermatitis Control Tool (ADCT) in assessing patient-perceived control of atopic dermatitis (AD). We evaluated levels of agreement between patient and clinician assessments of AD control using the ADCT and clinician global assessment of control, respectively, providing further support to the measurement properties of the ADCT.
